BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 31405379)

  • 1. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
    Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
    Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
    Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
    J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma.
    Wang K; Ling T; Wu H; Zhang J
    Oncol Rep; 2013 Mar; 29(3):1175-82. PubMed ID: 23292452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Methylation of Cancer Stem Cell Surface Markers as an Epigenetic Biomarker for Prognosis of Oral Squamous Cell Carcinoma.
    Han YK; Park HY; Park SG; Hwang JJ; Park HR; Yi JM
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylated promoters of tumor suppressor genes were identified in Crohn's disease patients.
    Kim TO; Han YK; Yi JM
    Intest Res; 2020 Jul; 18(3):297-305. PubMed ID: 32019290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
    Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
    Long NK; Kato K; Yamashita T; Makita H; Toida M; Hatakeyama D; Hara A; Mori H; Shibata T
    Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of differential promoter hypermethylated genes in primary oral squamous cell carcinoma.
    Khor GH; Froemming GR; Zain RB; Abraham MT; Thong KL
    Asian Pac J Cancer Prev; 2014; 15(20):8957-61. PubMed ID: 25374236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
    Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
    Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
    Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
    BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
    Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
    Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.